Categories: Latest

AiMeD Unveils Figure of Growth Rate of Indian Medical Device Industry During COVID-19 Pandemic

New Delhi, October 01, 2020: As India geared up to fight the COVID-19 crisis, the Association of Indian Medical Device Industry relentlessly worked at the fore front to combat the crisis. Mr. Rajiv Nath, Forum Coordinator, AiMED on behalf of the Indian Medical Device industry was in regular consultation with the Govt & assured Commerce Minister, Shri Piyush Goyal & Govt. full support to the Govt’s spirited fight against COVID-19 crisis. Huge efforts were put into increase medical device manufacturing capacity by AiMeD through its Members and beyond by reaching out to Garment Manufacturers, Automakers, Auto Component Manufacturers and Electronic Component Manufacturers as a preparedness for possible unprecedented, unpredictable demands.

AiMeD is an Umbrella Association of Indian Manufacturers of Medical Devices covering all types of Medical Devices including Consumables, Disposables, Equipment’s, Instruments, Electronics, Diagnostics, and Implants. With a Primary Membership of over 350 Manufacturers and additionally of over 200 Associate Members representing the interest of over 1200 Manufacturers of Medical Devices however, with over 2000 products AiMeD should be over 7000 factories and bigger than Pharma to address the manufacturer’s problems.

Mr. Rajiv Nath recognized that the government interventions under the able leadership of Cabinet Secretary, Shri Rajiv Gauba and DOP Secretary, Dr. P D Vaghela helped the Medical Devices industry scale up production during the pandemic. AiMeD worked closely with Govt. of India i.e. Dept. of Pharmaceuticals, Ministry of Commerce, NPPA & CDSCO etc. as a Facilitator between the Govt. and the Manufacturers of Medical Devices e.g. Gloves, Masks, Sanitizers, Ventilators, Diagnostic & Testing Kits for COVID-19 etc. for ramping up capacity and addressing Production bottlenecks in this National Emergency to fight against COVID-19 pandemic during the complete lockdown period.

AiMeD provided the Indian Govt., a single point of contact access to Domestic Manufacturers and on behalf of Manufacturers provided them various services like Advocacy on policy issues, Information services, Regulations for Medical Devices, Education and Training services, Testing Assistance and guidance for Quality Certification (ISO, CE, ICMED QMS), Lobbying for funding for R&D from the Govt, encourage innovations from member units, Improve clinician and patient access to the modern, innovative and reliable Medical Device technologies through organizing and supporting Meetings, Seminars, Symposia, Exhibitions and Demonstration, to promote global harmonization and make India a MedTech superpower & also strengthen India to be the 2nd factory in world for Medical Devices & a dependable Manufacturer of quality products in Global supply chain.

The Government of India through its flagship “Make in India” initiative relied heavily on the Indian manufacturers to meet the rising demand of essential healthcare equipment’s for the country, pushing the Indian medical devices sector to become self-reliant especially for the essential 39 COVID Medical Devices. AiMeD worked with QCI to expedite finalization of ICMED Plus Certification as well as with Consultants Consortium to provide online training on Quality Management System Certification to new entrepreneurs from Automakers, Garments, Textile, Auto parts Industry who had ventured into Medical Devices manufacturing to build capacity & capabilities to meet QCIs ICMED Certification and Regulatory Compliance so that they could have confidence to seek Global Certification of CE and US FDA Compliance for enabling Global Competitiveness. 4 batches of over 115 Manufacturers or their representatives were intensely trained over 7 modules over 11 sessions spread over 2 weeks in April &May 2020.

Before the outbreak of COVID-19, there were only 20 firms manufacturing 62 lacs PPE kits per year, but within two-three months, the number of manufacturers listed with AiMeD increased to 140 with 25.55 Crore annual capacity.

Similarly, the number of Indian firms manufacturing, ventilator manufacturers went up from 8 to 17, mask manufacturers from 30 to 108, swab manufacturers from zero to five and sanitizer manufacturers from 35 to 49 and RT PCR Kit manufacturer from 0 to 8.

Find the comparison sheet of the growth rate before & after COVID-19 with annual capacity below:

Comparison sheet of the growth rate of Medical Device Industry before & after COVID-19

AiMeD ensures convergence at one common platform, when needed, for ensuring overall growth of Indian Medical Devices Industry and further address the needs of all members of the Medical Device Industry irrespective of their affiliation or their company size. It also helps in wider dissemination of information to each player of the industry. AiMeD has been horizontally divided into common working groups like – R&D and Product Development, Legal & Tax Issues, Export Related Issues, Medical Device Regulatory Issues common to all vertical groups of different families of product lines with Zonal Representations and Cluster Heads.

“COVID-19 crisis has shown that Indian medical devices sector can rise to the challenge. When imports got disrupted, specific devices detailed with quantified production shortages and a focused Inter-Ministry Group coordinating with domestic manufacturers via AiMeD had addressed production bottlenecks and challenges so that not only capacity got utilized but also ramped up rapidly,” said Mr. Rajiv Nath.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

1 day ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

1 day ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

2 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

2 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

3 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

3 days ago